Botaneco Retains Investor Relations Firm
March 01 2012 - 7:21AM
PR Newswire (Canada)
QUEBEC CITY, March 1, 2012 /CNW/ - Botaneco Corp. ("Botaneco" or
the "Corporation") , a health science company focused on natural
ingredients in the personal care industry, is pleased to announce
that it has retained Newplanet Inc. ("Newplanet") to provide
Botaneco with strategic investor relations and communication
services. Newplanet is a specialty investor relations firm that
focuses strictly on companies that possess exceptional patented
technology within the health science industry. Newplanet,
which is based in Winnipeg, MB, was founded by Dr. Kevin
Richardson, who most recently worked with Botaneco through
SectorSpeak Inc. Prior to this Dr Richardson worked at DiaMedica
Inc., a biotechnology company, where he was co-inventor of the lead
drug program for Type 2 diabetes and latterly led the investor
relations program for over 4 years. "The future of the personal
health care and cosmetic industry is undoubtedly going 'green' as
consumers become more aware of the unwanted chemicals in these
products." stated Dr. Richardson. "Botaneco has exceptional
proprietary technology that not only replaces unwanted chemicals in
these products, but also improves their performance, versatility
and sustainability. I am thrilled to be part of a company
that has the potential to make a significant impact in such a
lucrative market". Pursuant to the agreement between Newplanet and
Botaneco, Newplanet will be responsible for designing and
implementing a customized investor relations strategy that clearly
identifies Botaneco's market position and potential.
Newplanet will also provide the Company with a number of other
services including but not limited to: ongoing capital markets
counsel; coordination of capital markets outreach with key members
of the professional investment community; and development of retail
broker relations. Under the terms of the agreement between
Botaneco and Newplanet, Botaneco will pay Newplanet an initial
monthly retainer fee of $3,000, rising to $5,000 upon the
achievement of certain corporate milestones. Botaneco has also
granted Newplanet 300,000 stock options today (the "Initial
Options") and has agreed to grant a further 200,000 additional
options upon the achievement of certain corporate milestones (the
"Additional Options"). Each Initial Option allows Newplanet
to acquire one common share of Botaneco until March 1, 2017 for a
price of $0.10 per share. The Additional Options will be priced at
or around market price at the time of their grant in compliance
with policies of the TSX Venture Exchange. The Initial Options are
governed by the stock option plan of the Corporation and will vest
over a one year period at a rate of 25% per quarter. The
initial contract term is 12 months and is effective March 1, 2012.
The Corporation also announces that it has granted today a total of
575,000 stock options to management and employees. A number of
150,000 stock options were granted to management while 425,000
stock options were granted to employees. Each stock option allows
the holder thereof to acquire one common share of Botaneco until
March 1, 2017 for a price of $0.10 per share. The options are
governed by the stock option plan of the Corporation and will vest
in three instalments on the date of grant, the first and second
anniversary of their date of grant. About Botaneco Corp. Botaneco
Corp. specializes in personal care, food and nutraceutical
ingredients. We are committed to developing groundbreaking
ingredients based on our patented technologies, and offering
multifunctional, tangible and documented benefits to formulators
and consumers alike. Botaneco is a global developer and
marketer of innovative technologies that help manufacturers meet
the consumers growing demand for natural, environmentally friendly,
personal healthcare products. A competitive advantage to
Botaneco's patented technology over traditional products in the
'green sector' is the ability to significantly enhance the
performance and versatility of these skin and hair care
products. The company has also been awarded the Canadian
Agri-Food Award of Excellence for its flaxseed technology marketed
in the natural food industry. Botaneco holds patents for its
Hydresia® Oleosome, Vegelatum® Gel, Dermylex® Whey Protein and
Flaxseed De-hulling technology. Neither TSX Venture Exchange nor
its Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release. Botaneco Corp. CONTACT:
Murray BruceCFOBotaneco Corp.(403) 668-4612brucem@botaneco.ca Kevin
Richardson, PhDPresident & CEONewplanet Inc(204)
899-3868Kevin@newplanetinc.ca
Copyright
Natunola Agritech, Inc. (TSXV:BOT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Natunola Agritech, Inc. (TSXV:BOT)
Historical Stock Chart
From Jul 2023 to Jul 2024